help button home button Am J Pathol JNCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Melhem, M. F.
Right arrow Articles by Gill, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melhem, M. F.
Right arrow Articles by Gill, T. J., 3d

American Journal of Pathology, Vol 139, 45-51, Copyright © 1991 by American Society for Investigative Pathology


REGULAR ARTICLES

Genetic control of susceptibility to diethylnitrosamine and dimethylbenzanthracene carcinogenesis in rats

MF Melhem, HW Kunz and TJ Gill 3d
Department of Pathology, University of Pittsburgh, School of Medicine, Pennsylvania.

The susceptibility to cancer induction after a single dose of diethylnitrosamine in male rats and a single dose of dimethylbenzanthracene in female rats was examined in the grc- strain R16 and the grc+ strain ACP, both of which have the same major histocompatibility complex genes but differ in the grc region. No tumor- promoting regimens were used, and the animals were fed only laboratory chou. The R16 males developed liver cancer and the R16 females developed breast cancer, there also were malignancies in other organs in some animals. By contrast, the ACP males did not develop any malignancies, and the ACP females had a significantly lower prevalence of malignant tumors. Thus the susceptibility to cancer in these two strains of rats has a genetic basis associated with genes in the grc region, and is independent of the carcinogen used, the action of a promoter, and the sex of the animals.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society for Investigative Pathology.